Though currently littered with penny stocks, the landscape for investing in marijuana is improving.  Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals.  Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management. 

Direct download: Market_Foolery_05_21_2018.mp3
Category:podcast -- posted at: 12:00pm EDT